An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...

Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to ...

WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go ...

Tariffs, including the 15% rate for most imports from the EU, would raise consumer prices by 1.8% in the short run, according ...

Higher "reciprocal" tariffs are expected to go into effect this Friday. A few trade deals could still be struck with trading ...

A tariff rate of 15% is “challenging” but avoids a rate of 30% – which would have “closed the market” in the US, Ireland’s ...

US President Donald Trump and European Commission President Ursula von der Leyen clinched a deal late on Sunday that includes ...

Excerpts from recent editorials in the United States and abroad: ___ July 28 The Washington Post on RFK Jr.'s proposed limit on pharmaceutical ads Since stepping into the helm at the Department of ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal ...

Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

One economist told Newsweek that companies may be wary of "consumer backlash" if they hike prices to mitigate the tariffs' ...